The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals HIV-Causal Collaboration Aids 24 (1), 123-137, 2010 | 545 | 2010 |
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study HIV-CAUSAL Collaboration* Annals of internal medicine 154 (8), 509-515, 2011 | 339 | 2011 |
Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need … S Lodi, A Phillips, G Touloumi, R Geskus, L Meyer, R Thiébaut, ... Clinical infectious diseases 53 (8), 817-825, 2011 | 261 | 2011 |
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion S Lodi, M Guiguet, D Costagliola, M Fisher, A De Luca, K Porter, ... Journal of the National Cancer Institute 102 (11), 784-792, 2010 | 157 | 2010 |
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion S Lodi, L Meyer, AD Kelleher, M Rosinska, J Ghosn, M Sannes, K Porter Archives of internal medicine 172 (16), 1252-1255, 2012 | 129 | 2012 |
The undiagnosed HIV epidemic in France and its implications for HIV screening strategies V Supervie, JDA Ndawinz, S Lodi, D Costagliola Aids 28 (12), 1797-1804, 2014 | 120 | 2014 |
Effect estimates in randomized trials and observational studies: comparing apples with apples S Lodi, A Phillips, J Lundgren, R Logan, S Sharma, SR Cole, A Babiker, ... American journal of epidemiology 188 (8), 1569-1577, 2019 | 111 | 2019 |
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ... The Lancet 376 (9738), 340-345, 2010 | 97 | 2010 |
Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use–associated infective endocarditis SD Kimmel, AY Walley, Y Li, BP Linas, S Lodi, D Bernson, RD Weiss, ... JAMA network open 3 (10), e2016228-e2016228, 2020 | 78 | 2020 |
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries HIV-CAUSAL Collaborationa Clinical Infectious Diseases 54 (9), 1364-1372, 2012 | 72 | 2012 |
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study S Lodi, A Phillips, R Logan, A Olson, D Costagliola, S Abgrall, ... The lancet HIV 2 (8), e335-e343, 2015 | 63 | 2015 |
Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord Socio-economic Inequalities and HIV Writing Group for Collaboration of ... Aids 28 (15), 2297-2306, 2014 | 57 | 2014 |
Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe A Judd, R Lodwick, A Noguera‐Julian, DM Gibb, K Butler, D Costagliola, ... HIV medicine 18 (3), 171-180, 2017 | 54 | 2017 |
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study HIV-Causal Collaboration Aids 26 (13), 1691-1705, 2012 | 54 | 2012 |
Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults HW Jaffe, BL De Stavola, LM Carpenter, K Porter, DR Cox, ... Aids 25 (11), 1395-1403, 2011 | 50 | 2011 |
Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts X Huang, S Lodi, Z Fox, W Li, A Phillips, K Porter, I Lutsar, A Kelleher, N Li, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (4), 441-446, 2013 | 49 | 2013 |
Association between mortality rates and medication and residential treatment after in‐patient medically managed opioid withdrawal: a cohort analysis AY Walley, S Lodi, Y Li, D Bernson, H Babakhanlou‐Chase, T Land, ... Addiction 115 (8), 1496-1508, 2020 | 45 | 2020 |
Risk of tuberculosis following HIV seroconversion in high-income countries S Lodi, J Del Amo, AA Monforte, S Abgrall, C Sabin, C Morrison, H Furrer, ... Thorax 68 (3), 207-213, 2013 | 40 | 2013 |
Is there an anti‐inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database S Lodi, SJW Evans, P Egger, J Carpenter British journal of clinical pharmacology 69 (1), 85-94, 2010 | 40 | 2010 |
COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort study TC Bouton, S Lodi, J Turcinovic, SE Weber, E Quinn, C Korn, J Steiner, ... MedRxiv, 2021.03. 30.21254655, 2021 | 39 | 2021 |